Odette A. Fahmi

Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction

Odette A. Fahmi, Susan Hurst, David R. Plowchalk et al. · Drug Metabolism and Disposition · 2009 · 210 citations

A Combined Model for Predicting CYP3A4 Clinical Net Drug-Drug Interaction Based on CYP3A4 Inhibition, Inactivation, and Induction Determined in Vitro

Odette A. Fahmi, Tristan S. Maurer, Mary Kish et al. · Drug Metabolism and Disposition · 2008 · 198 citations

Cytochrome P450 3A4 mRNA Is a More Reliable Marker than CYP3A4 Activity for Detecting Pregnane X Receptor-Activated Induction of Drug-Metabolizing Enzymes

Odette A. Fahmi, Mary Kish, Sherri Boldt et al. · Drug Metabolism and Disposition · 2010 · 134 citations

Use of Immortalized Human Hepatocytes to Predict the Magnitude of Clinical Drug-Drug Interactions Caused by CYP3A4 Induction

Sharon L. Ripp, Jessica B. Mills, Odette A. Fahmi et al. · Drug Metabolism and Disposition · 2006 · 118 citations

Unexpected Effect of Rifampin on the Pharmacokinetics of Linezolid: In Silico and In Vitro Approaches to Explain Its Mechanism

Kuan Gandelman, Tong Zhu, Odette A. Fahmi et al. · The Journal of Clinical Pharmacology · 2010 · 109 citations

Healthy Subjects, Antiparasitic Agent, Pharmacotherapy +22